+65 6515 0110

08 Apr 14



PXi Touch at University of Cambridge Provides More Accurate Results By Imaging Fluorescent and Chemiluminescent Proteins on one Blot

Cambridge, UK: Syngene, a world-leading manufacturer of image analysis solutions is delighted to announce its PXi Touch imaging system is being used in a new application by scientists at the UK’s University of Cambridge to visualise multiplex fluorescent and chemiluminescent labelled proteins on the same Western blots. This is contributing to rapidly providing researchers there with more accurate and reproducible results.

Researchers in the Department of Pharmacology at the University of Cambridge are using a PXi Touch multi-application imager to analyse proteins on Western blots stained with chemiluminescent and multiplex fluorescent dyes.

Dr Emily Taylor, Laboratory Manager in the Department of Pharmacology commented: “We want to perform multiplex fluorescent Westerns because we can use the same blot to probe for different proteins as we’re looking at proteins ranging 30 kDa to 260 kDa and it is quicker and easier to use just one blot rather than looking at multiple blots for each protein. For this application, we assessed the PXi Touch alongside a laser based scanning system and chose the PXi Touch because the touch screen software is easy to use and the camera is very sensitive.”

Dr Taylor continued: “Since we began using the PXi Touch system, we have discovered that the imaging capability is so good we can interchangeably use multiplex fluorescence and chemi dyes. We now use chemi to detect proteins expressed by our house keeping genes and fluorescence for the proteins of interest. We do this as fluorescence has a better linear range but chemi is more sensitive so we mix and match the two detection methods on the same blot and this is helping us to obtain greater accuracy and reproducibility of results.”

Laura Sullivan, Syngene’s Divisional Manager, stated: “We are excited to hear that our latest imaging technology is being utilised at such a prestigious institute for this novel mixed imaging application. Their research shows scientists that using a PXi Touch means they can work smarter to obtain optimum results, time after time from their Western blots.”


For Further Information Contact:
Jayne Arthur, Synoptics Health, Beacon House, Nuffield Road, Cambridge, CB4 1TF, UK.
Tel: +44(0) 1223-727123 | Fax +44 (0) 1223-727101
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.  | Web site: www.syngene.com
Twitter: @TeamSyngene

Editor Contact:
Dr Sue Pearson, Director, International Science Writer, PO Box 170, Hitchin, Hertfordshire SG5 3GD, UK.
Tel/Fax: +44 (0) 1462-635327 | Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Web: www.internationalsciencewriter.com | Twitter: @isciencewriter

Note to Editors

About Syngene
Syngene is a world-leading supplier of integrated imaging solutions for analysis and documentation of gel-based information. Syngene’s systems are used by more than 10,000 research organisations and over 50,000 individual scientists world-wide and include many of the world’s top pharmaceutical companies and major research institutes.

Syngene, founded in 1997, is a division of the Synoptics Group of the AIM listed Scientific Digital Imaging Company based in Cambridge, UK. The Group’s other divisions, Syncroscopy and Synbiosis, specialise in digital imaging solutions for microscopy and microbial applications respectively. Synoptics currently employs 40 people in its UK and subsidiary operation in Frederick, USA.



insta bioAnalytik was set up in Year 2000 as a sales and marketing office, offering solutions for the scientific and medical communities... more